Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.249
+0.008 (3.32%)
At close: Apr 26, 2024, 4:00 PM
0.257
+0.008 (3.17%)
After-hours: Apr 26, 2024, 4:41 PM EDT
Asensus Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Asensus Surgical stock has a target of 0.35, which predicts an increase of 40.56% from the current stock price of 0.25.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for ASXC stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $2 → $0.35 | Strong Buy → Hold | Downgrades | $2 → $0.35 | +40.56% | Apr 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 | Strong Buy | Maintains | $2 | +703.21% | Mar 22, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +703.21% | Nov 15, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $1 | Buy | Reiterates | $1 | +301.61% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
12.54M
from 8.58M
Increased by 46.23%
Revenue Next Year
22.66M
from 12.54M
Increased by 80.64%
EPS This Year
-0.19
from -0.31
EPS Next Year
-0.15
from -0.19
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 15.0M | 33.1M | 54.0M | 111.8M | 163.1M |
Avg | 12.5M | 22.7M | 52.4M | 108.6M | 158.4M |
Low | 10.1M | 12.6M | 50.4M | 104.3M | 152.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 75.0% | 163.9% | 138.1% | 113.3% | 50.1% |
Avg | 46.2% | 80.6% | 131.3% | 107.2% | 45.9% |
Low | 17.7% | 0.8% | 122.3% | 99.1% | 40.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.19 | -0.14 | -0.08 | 0.04 | 0.15 |
Avg | -0.19 | -0.15 | -0.08 | 0.04 | 0.14 |
Low | -0.19 | -0.16 | -0.08 | 0.04 | 0.14 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 260.3% |
Avg | - | - | - | - | 250.0% |
Low | - | - | - | - | 236.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.